Literature DB >> 15574596

Tissue-specific tumor suppressor activity of retinoblastoma gene homologs p107 and p130.

Jan-Hermen Dannenberg1, Leontine Schuijff, Marleen Dekker, Martin van der Valk, Hein te Riele.   

Abstract

The retinoblastoma gene family consists of three genes: RB, p107, and p130. While loss of pRB causes retinoblastoma in humans and pituitary gland tumors in mice, tumorigenesis in other tissues may be suppressed by p107 and p130. To test this hypothesis, we have generated chimeric mice from embryonic stem cells carrying compound loss-of-function mutations in the Rb gene family. We found that Rb/p107- and Rb/p130-deficient mice were highly cancer prone. We conclude that in a variety of tissues tumor development by loss of pRB is suppressed by its homologs p107 and p130. The redundancy of the retinoblastoma proteins in vivo is reflected by the behavior of Rb-family-defective mouse embryonic fibroblasts in vitro.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15574596      PMCID: PMC534655          DOI: 10.1101/gad.322004

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  71 in total

Review 1.  Second primary tumors in patients with retinoblastoma. A review of the literature.

Authors:  A C Moll; S M Imhof; L M Bouter; K E Tan
Journal:  Ophthalmic Genet       Date:  1997-03       Impact factor: 1.803

2.  Domains A and B in the Rb pocket interact to form a transcriptional repressor motif.

Authors:  K N Chow; D C Dean
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes.

Authors:  A S Lundberg; R A Weinberg
Journal:  Mol Cell Biol       Date:  1998-02       Impact factor: 4.272

4.  pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes.

Authors:  R K Hurford; D Cobrinik; M H Lee; N Dyson
Journal:  Genes Dev       Date:  1997-06-01       Impact factor: 11.361

5.  Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma.

Authors:  K Helin; K Holm; A Niebuhr; H Eiberg; N Tommerup; S Hougaard; H S Poulsen; M Spang-Thomsen; P Norgaard
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-24       Impact factor: 11.205

6.  Mutations in the retinoblastoma-related gene RB2/p130 in lung tumors and suppression of tumor growth in vivo by retrovirus-mediated gene transfer.

Authors:  P P Claudio; C M Howard; C Pacilio; C Cinti; G Romano; C Minimo; N M Maraldi; J D Minna; L Gelbert; L Leoncini; G M Tosi; P Hicheli; M Caputi; G G Giordano; A Giordano
Journal:  Cancer Res       Date:  2000-01-15       Impact factor: 12.701

7.  Recurrent allelic deletions of chromosome arms 15q and 16q in human small cell lung carcinomas.

Authors:  S E Stanton; S W Shin; B E Johnson; M Meyerson
Journal:  Genes Chromosomes Cancer       Date:  2000-03       Impact factor: 5.006

8.  Immunocytochemical analysis of the mouse retina.

Authors:  S Haverkamp; H Wässle
Journal:  J Comp Neurol       Date:  2000-08-14       Impact factor: 3.215

9.  Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-)mice.

Authors:  L Yamasaki; R Bronson; B O Williams; N J Dyson; E Harlow; T Jacks
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

Review 10.  Cancer cell cycles.

Authors:  C J Sherr
Journal:  Science       Date:  1996-12-06       Impact factor: 47.728

View more
  68 in total

Review 1.  Racing to block tumorigenesis after pRb loss: an innocuous point mutation wins with synthetic lethality.

Authors:  Frederick Bauzon; Liang Zhu
Journal:  Cell Cycle       Date:  2010-06-01       Impact factor: 4.534

Review 2.  Cancer models in Caenorhabditis elegans.

Authors:  Natalia V Kirienko; Kumaran Mani; David S Fay
Journal:  Dev Dyn       Date:  2010-05       Impact factor: 3.780

3.  Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm-deficient mice.

Authors:  Takeshi Suzuki; Ken-ichi Minehata; Keiko Akagi; Nancy A Jenkins; Neal G Copeland
Journal:  EMBO J       Date:  2006-07-06       Impact factor: 11.598

4.  Developmental stage-specific proliferation and retinoblastoma genesis in RB-deficient human but not mouse cone precursors.

Authors:  Hardeep P Singh; Sijia Wang; Kevin Stachelek; Sunhye Lee; Mark W Reid; Matthew E Thornton; Cheryl Mae Craft; Brendan H Grubbs; David Cobrinik
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-13       Impact factor: 11.205

5.  Targeting Rb inactivation in cancers by synthetic lethality.

Authors:  Gabriel M Gordon; Wei Du
Journal:  Am J Cancer Res       Date:  2011-06-30       Impact factor: 6.166

6.  Mutation of p107 exacerbates the consequences of Rb loss in embryonic tissues and causes cardiac and blood vessel defects.

Authors:  Seth D Berman; Julie C West; Paul S Danielian; Alicia M Caron; James R Stone; Jacqueline A Lees
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-19       Impact factor: 11.205

7.  Positive regulation of minichromosome maintenance gene expression, DNA replication, and cell transformation by a plant retinoblastoma gene.

Authors:  Paolo A Sabelli; George Hoerster; Lucina E Lizarraga; Sara W Brown; William J Gordon-Kamm; Brian A Larkins
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-20       Impact factor: 11.205

8.  Structural Conservation and E2F Binding Specificity within the Retinoblastoma Pocket Protein Family.

Authors:  Tyler J Liban; Michael J Thwaites; Frederick A Dick; Seth M Rubin
Journal:  J Mol Biol       Date:  2016-08-25       Impact factor: 5.469

9.  p107 in the public eye: an Rb understudy and more.

Authors:  Stacey E Wirt; Julien Sage
Journal:  Cell Div       Date:  2010-04-02       Impact factor: 5.130

10.  The retinoblastoma protein and its homolog p130 regulate the G1/S transition in pancreatic beta-cells.

Authors:  George Harb; Rupangi C Vasavada; David Cobrinik; Andrew F Stewart
Journal:  Diabetes       Date:  2009-06-09       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.